Celularity Inc

CELU

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001752828

SEC filings (opens in a new tab)

Insider trades, last 90 days

None

No open-market purchases or sales were filed in the last 90 days.

View insider trades

13F holders, Q2 2026

39

+1 vs. Q1 2026
Total value $2.44M

View 13F holders

Superinvestors holding CELU

0

None of the superinvestors held CELU at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by CELU insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Jan 17, 20245:22 PM ET	Jan 12, 2024	Lim Kok Thay and 2 others10% Owner	PPurchaseClass A Common Stock	+21.41M	$0.249	+$5.33M	51.47M	+71.2%	SEC
Jan 17, 20245:22 PM ET	Jan 12, 2024	Lim Kok Thay and 2 others10% Owner	PPurchaseClass A Common Stock · Derivative	+21.85M	$0.125	+$2.73M	16.5M	–	SEC
Oct 10, 20239:48 PM ET	Sep 29 – Oct 5, 2023	Hariri Robert JChief Executive Officer	PPurchaseClass A Common Stock	+18.42M	$0.162	+$2.98M	28.57M	+181.5%	SEC
Oct 5, 2023	Sep 29 – Oct 5, 2023	Sorrento Therapeutics, Inc.10% Owner	SSaleClass A Common Stock	−15.37M	–	–	5.05M	−75.3%	SEC
Jun 22, 20234:32 PM ET	Jun 20, 2023	Genting Berhad10% Owner	PPurchaseClass A Common Stock · Derivative	+3M	$0.125	+$375K	3M	–	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in CELU at the end of Q2 2026.

Institutions holding CELU in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
C V STARR & CO INC	764,069	$1.58M	0.84%	00.0%	Unchanged
VANGUARD CAPITAL MANAGEMENT LLC	621,105	$371.42K	0.00%	00.0%	Unchanged
GEODE CAPITAL MANAGEMENT, LLC	167,150	$99.96K	0.00%	−23,926−12.5%	Reduced
CITADEL ADVISORS LLC	99,054	$59.22K	0.00%	+99,054	New
VANGUARD FIDUCIARY TRUST CO	79,874	$47.77K	0.00%	00.0%	Unchanged